Noticias de Eulerpool Elevation Oncology

Elevation Oncology Noticias de Acciones

Elevation Oncology es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Elevation Oncology.

• 15 de mayo ·

  Yahoo
  Elevation Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates
• 25 de abril ·

  Yahoo
  Elevation Oncology Presents Preclinical Proof-of-Concept Data for EO-1022 at the American Association for Cancer Research (AACR) Annual Meeting 2025
• 7 de enero ·

  Yahoo
  Why Elevation Oncology (ELEV) Is Among the Best Penny Stocks to Invest In According to Media?
• 19 de diciembre ·

  Yahoo
  Bipartisan lawmakers appear 'aligned' on PBM, insurance reform
• 12 de diciembre ·

  Yahoo
  Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid Tumors
• 5 de diciembre ·

  Yahoo
  Elevation Oncology Presents Preclinical Proof-of-Concept Data Supporting Combination Potential of EO-3021 with VEGFR2 or PD-1 Inhibitors at ESMO Immuno-Oncology Annual Congress 2024
• 26 de noviembre ·

  Yahoo
  Elevation Oncology to Present at the Piper Sandler 36th Annual Healthcare Conference
• 6 de noviembre ·

  Yahoo
  Elevation Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business Achievements
• 10 de octubre ·

  Yahoo
  What Makes Elevation Oncology (ELEV) a New Strong Buy Stock
• 9 de octubre ·

  Yahoo
  Empery Asset Management's Strategic Acquisition in Elevation Oncology